• Publications
  • Influence
Mutation profile in non-small cell lung cancer: Analysis of a Brazilian population.
e19115 Background: Non-small cell lung cancer (NSCLC) is known to harbor molecular mutations or rearrangements predictive to a variety of targeted therapies, which have been increasing the overallExpand
  • 6
  • 1
Next-generation sequencing (NGS) in metastatic breast cancer (mBC) patients: Translation from sequence data into clinical practice.
133 Background: A considerable number of patients with mBC progress after exhausting all approved standard therapies but maintain an adequate performance status and could be candidates for furtherExpand
  • 4
Successful hepatectomy for metastatic squamous cell carcinoma of the anal canal-a case report.
Despite rare, metastatic anal carcinoma confers a poor prognosis. Systemic chemotherapy is the mainstay of treatment for advanced disease while the role of biologics and/or surgical resection ofExpand
  • 2
Palliative intra-arterial high-dose cisplatin for inoperable sarcoma.
e21521 Background: Inoperable sarcoma may be associated with limiting local symptoms . To date, there are no data regarding the efficacy of palliative intra-arterial cisplatin for unresectableExpand
Brain metastasis are more frequent in EGFR mutated than in wild-type lung adenocarcinoma.
e19069 Background: Brain metastasis (BM) are an event relatively frequent in the clinical course of patients with lung adenocarcinoma. Despite all advances in therapeutical approach, it still has aExpand
Impact of comprehensive tumor profiling using a targeted next-generation sequencing panel in Brazil.
e22175 Background: Several patients with advanced cancer maintain good performance status even after disease progression following all standard therapies. Next-generation sequencing (NGS) is aExpand
Next-generation sequencing in metastatic lung cancer patients: Translation from sequence data into clinical practice.
e12521 Background: Several patients with lung cancer (LC) maintain good performance status even after disease progression following all standard therapies. More recently, targeted therapies have beenExpand
The Brazilian experience with biochemotherapy for metastatic melanoma: Long-term results in 163 patients.
e20073 Background: The long term survival impact of biochemotherapy (BioCT) for patients with metastatic melanoma (MM) is not well established in the literature. We performed a retrospective analysisExpand